Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.1K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.1K
Blood Transfusion01:15

Blood Transfusion

2.4K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.4K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

14.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
The Placebo Effect01:54

The Placebo Effect

6.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of a corrugated Dion-Jacobson 2D perovskite as an additive in 3D MAPbBr<sub>3</sub> perovskite-based light emitting diodes.

Nanoscale advances·2023
Same author

Reply to the 'Comment on "Metal-organic green dye: chemical and physical insight into a modified Zn-benzoporphyrin for dye-sensitized solar cells"' by R. Steer, <i>RSC Advances</i>, 2018, DOI: 10.1039/c8ra00213d.

RSC advances·2022
Same author

Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2020
Same author

[Disease-related knowledge acquisition through structured patient information in rheumatoid arthritis (StruPI-RA) : First results of the StruPI-RA study in Germany].

Zeitschrift fur Rheumatologie·2020
Same author

Intracorporeal versus extracorporeal anastomosis for minimally invasive right colectomy: the end of the discussion is near.

Techniques in coloproctology·2020
Same author

Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA.

Transfusion medicine (Oxford, England)·2019

Related Experiment Video

Updated: Feb 8, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

8.3K

Transfusion medicine and surgery.

V De Angelis1, L De Marco

  • 1Blood Bank and Clinical Pathology Laboratory, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.

Surgical Technology International
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Minimizing blood transfusions during surgery for severe anemia is crucial. This review explores defining the lowest safe transfusion amount and reducing associated risks like infection and immune reactions.

More Related Videos

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.6K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.4K

Related Experiment Videos

Last Updated: Feb 8, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

8.3K
Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.6K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.4K

Area of Science:

  • Surgical Medicine
  • Anesthesiology
  • Transfusion Medicine

Background:

  • Severe anemia poses significant surgical mortality risks due to blood loss and tissue hypoxia.
  • Blood transfusions, while necessary, carry their own risks, including infectious diseases and immunological side effects.
  • Balancing the risks of anemia and transfusion is critical for patient safety in surgery.

Purpose of the Study:

  • To define the minimum blood transfusion threshold required for surgical patients with severe anemia.
  • To identify strategies for minimizing or eliminating the risks associated with necessary blood transfusions.

Main Methods:

  • Literature review focusing on transfusion guidelines and risk mitigation strategies in surgical anemia.
  • Analysis of current practices and evidence regarding blood transfusion thresholds.
  • Exploration of immunological and infectious complications of allogeneic blood transfusions.

Main Results:

  • Establishing a precise "lowest amount" of blood transfusion requires careful patient-specific assessment.
  • Reducing transfusion volumes minimizes risks but necessitates optimizing oxygen delivery through other means.
  • Strategies exist to mitigate post-transfusion risks, including donor selection and blood product management.

Conclusions:

  • Optimizing perioperative management is key to reducing mortality in anemic surgical patients.
  • Defining and adhering to minimal transfusion requirements can significantly improve surgical outcomes.
  • Further research into transfusion alternatives and risk reduction is warranted.